Jakafi in Patients with Polycythemia Vera

A Case-Based Presentation:

Jakafi® (ruxolitinib) in Patients with Polycythemia Vera who have an Inadequate Response to Hydroxyurea

Featured Speaker:
Rebecca Schiff, RN
University of California San Francisco
San Francisco, CA

Register by: Thursday, November 14, 2019
http://bit.ly/inc6359
To register manually, please contact your Incyte representative Tanya Brubaker at (510) 332-3986 or tbrubaker@incyte.com with the following information: name, title/degree, state(s) and state license #(s), affiliation, address, phone, and e-mail